233 related articles for article (PubMed ID: 22012890)
1. Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.
Yogesha SD; Sharff AJ; Giovannini M; Bricogne G; Izard T
Protein Sci; 2011 Dec; 20(12):2113-20. PubMed ID: 22012890
[TBL] [Abstract][Full Text] [Related]
2. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.
Shimizu T; Seto A; Maita N; Hamada K; Tsukita S; Tsukita S; Hakoshima T
J Biol Chem; 2002 Mar; 277(12):10332-6. PubMed ID: 11756419
[TBL] [Abstract][Full Text] [Related]
4. Conformational flexibility determines the Nf2/merlin tumor suppressor functions.
Primi MC; Rangarajan ES; Patil DN; Izard T
Matrix Biol Plus; 2021 Dec; 12():100074. PubMed ID: 34337379
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
Lallemand D; Saint-Amaux AL; Giovannini M
J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence resonance energy transfer analysis of merlin conformational changes.
Hennigan RF; Foster LA; Chaiken MF; Mani T; Gomes MM; Herr AB; Ip W
Mol Cell Biol; 2010 Jan; 30(1):54-67. PubMed ID: 19884346
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of Short Linear Motif-Based Interactions of the FERM Domains of Ezrin, Radixin, Moesin, and Merlin.
Ali M; Khramushin A; Yadav VK; Schueler-Furman O; Ivarsson Y
Biochemistry; 2023 Jun; 62(11):1594-1607. PubMed ID: 37224425
[TBL] [Abstract][Full Text] [Related]
8. Two Sides of the Coin: Ezrin/Radixin/Moesin and Merlin Control Membrane Structure and Contact Inhibition.
Michie KA; Bermeister A; Robertson NO; Goodchild SC; Curmi PMG
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018575
[TBL] [Abstract][Full Text] [Related]
9. FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.
Mani T; Hennigan RF; Foster LA; Conrady DG; Herr AB; Ip W
Mol Cell Biol; 2011 May; 31(10):1983-96. PubMed ID: 21402777
[TBL] [Abstract][Full Text] [Related]
10. The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product.
Kang BS; Cooper DR; Devedjiev Y; Derewenda U; Derewenda ZS
Acta Crystallogr D Biol Crystallogr; 2002 Mar; 58(Pt 3):381-91. PubMed ID: 11856822
[TBL] [Abstract][Full Text] [Related]
11. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
[TBL] [Abstract][Full Text] [Related]
12. Merlin tumor suppressor function is regulated by PIP2-mediated dimerization.
Hennigan RF; Thomson CS; Stachowski K; Nassar N; Ratner N
PLoS One; 2023; 18(2):e0281876. PubMed ID: 36809290
[TBL] [Abstract][Full Text] [Related]
13. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
15. Self-masking in an intact ERM-merlin protein: an active role for the central alpha-helical domain.
Li Q; Nance MR; Kulikauskas R; Nyberg K; Fehon R; Karplus PA; Bretscher A; Tesmer JJ
J Mol Biol; 2007 Feb; 365(5):1446-59. PubMed ID: 17134719
[TBL] [Abstract][Full Text] [Related]
16. Merlin: the wizard requires protein stability to function as a tumor suppressor.
Morrow KA; Shevde LA
Biochim Biophys Acta; 2012 Dec; 1826(2):400-6. PubMed ID: 22750751
[TBL] [Abstract][Full Text] [Related]
17. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain.
Pearson MA; Reczek D; Bretscher A; Karplus PA
Cell; 2000 Apr; 101(3):259-70. PubMed ID: 10847681
[TBL] [Abstract][Full Text] [Related]
18. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex.
Gladden AB; Hebert AM; Schneeberger EE; McClatchey AI
Dev Cell; 2010 Nov; 19(5):727-39. PubMed ID: 21074722
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of the binding of Merlin FERM domain to the E3 ubiquitin ligase substrate adaptor DCAF1.
Li Y; Wei Z; Zhang J; Yang Z; Zhang M
J Biol Chem; 2014 May; 289(21):14674-81. PubMed ID: 24706749
[TBL] [Abstract][Full Text] [Related]
20. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.
Lallemand D; Curto M; Saotome I; Giovannini M; McClatchey AI
Genes Dev; 2003 May; 17(9):1090-100. PubMed ID: 12695331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
